IL-4(38-37)-PE38KDEL immunotoxin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IL-4(38-37)-PE38KDEL immunotoxin, covering 2013-12-18 to 2013-12-18. Get the full timeline:
Most recent: Clinical Trial Update: IL-4(38-37)-PE38KDEL Immunotoxin in Treating Patients With Recurrent Malignant Astrocytoma [Phase 1]